In Brief: OTC "feedback" meeting on hydroquinone
This article was originally published in The Tan Sheet
Executive Summary
OTC "feedback" meeting on hydroquinone: FDA will meet with representatives from Kodak, Dep, Medicis Pharmaceutical, Kiwi Brands, the American Health Foundation and the Nonprescription Drug Manufacturers Association to discuss the skin bleaching ingredient on Dec. 4 at 1 p.m. in Conference Room S-300, 9201 Corporate Blvd., Rockville, Md. The meeting, which is open to the public, is part of an otherwise-closed all-day session of the Carcinogenicity Assessment Committee. FDA held a "feedback" meeting to collect information on the ingredient's possible link to skin discoloration in July ("The Tan Sheet" July 15, p. 9)...You may also be interested in...
People In Brief
In Brief
Supplement GMP Warning Letters Make Modest Debut In 2010
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: